-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LRio2MVYWRH4SYBpKTL1PGHn2AhR9M8ahC7Qs3bRlefjb50dXg1RtD6EOx1JFJct zKefdOjtWbzyxyhgM5wUKg== 0001019056-07-000832.txt : 20070912 0001019056-07-000832.hdr.sgml : 20070912 20070912112342 ACCESSION NUMBER: 0001019056-07-000832 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070912 DATE AS OF CHANGE: 20070912 GROUP MEMBERS: ADAM BENOWITZ GROUP MEMBERS: VISION CAPITAL ADVISORS, LLC GROUP MEMBERS: VISION OPPORTUNITY MASTER FUND, LTD. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDISTEM LABORATORIES, INC. CENTRAL INDEX KEY: 0001186519 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 861047317 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-83121 FILM NUMBER: 071112480 BUSINESS ADDRESS: STREET 1: 2027 E. CEDAR ST. CITY: TEMPE STATE: AZ ZIP: 85281 BUSINESS PHONE: (954) 727-3662 MAIL ADDRESS: STREET 1: 2027 E. CEDAR ST. CITY: TEMPE STATE: AZ ZIP: 85281 FORMER COMPANY: FORMER CONFORMED NAME: SGC HOLDINGS INC DATE OF NAME CHANGE: 20020905 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: VISION OPPORTUNITY MASTER FUND, LTD. CENTRAL INDEX KEY: 0001349985 IRS NUMBER: 270120759 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: C/O VISION CAPITAL ADVISORS, LLC STREET 2: 20 WEST 55TH STREET, 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (212) 849-8228 MAIL ADDRESS: STREET 1: C/O VISION CAPITAL ADVISORS, LLC STREET 2: 20 WEST 55TH STREET, 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: Vision Opportunity Master Fund Ltd DATE OF NAME CHANGE: 20060117 SC 13G 1 medistem_13g.txt SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Medistem Laboratories, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $0.0001 per share - -------------------------------------------------------------------------------- (Title of Class of Securities) 58501F 10 8 ----------------------------------------- (CUSIP Number) February 3, 2006 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). - -------------------------- ---------------------- CUSIP No. 58501F 10 8 SCHEDULE 13G Page 2 of 9 Pages - -------------------------- ---------------------- - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Vision Opportunity Master Fund, Ltd. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands - -------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES BENEFICIALLY 0 OWNED BY --------------------------------------------------- EACH 6 SHARED VOTING POWER REPORTING PERSON 14,236,466 WITH --------------------------------------------------- 7 SOLE DISPOSITIVE POWER 0 --------------------------------------------------- 8 SHARED DISPOSITIVE POWER 14,236,466 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 14,236,466 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES * [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 9.99% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON * CO - -------------------------------------------------------------------------------- - -------------------------- ---------------------- CUSIP No. 58501F 10 8 SCHEDULE 13G Page 3 of 9 Pages - -------------------------- ---------------------- - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Vision Capital Advisors, LLC (formerly known as Vision Opportunity Capital Management, LLC) - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES BENEFICIALLY 0 OWNED BY --------------------------------------------------- EACH 6 SHARED VOTING POWER REPORTING PERSON 14,236,466 WITH --------------------------------------------------- 7 SOLE DISPOSITIVE POWER 0 --------------------------------------------------- 8 SHARED DISPOSITIVE POWER 14,236,466 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 14,236,466 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES * [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 9.99% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON * IA - -------------------------------------------------------------------------------- - -------------------------- ---------------------- CUSIP No. 58501F 10 8 SCHEDULE 13G Page 4 of 9 Pages - -------------------------- ---------------------- - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Adam Benowitz - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION US Citizen - -------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES BENEFICIALLY 0 OWNED BY --------------------------------------------------- EACH 6 SHARED VOTING POWER REPORTING PERSON 14,236,466 WITH --------------------------------------------------- 7 SOLE DISPOSITIVE POWER 0 --------------------------------------------------- 8 SHARED DISPOSITIVE POWER 14,236,466 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 14,236,466 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES * [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 9.99% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON * IN - -------------------------------------------------------------------------------- - -------------------------- ---------------------- CUSIP No. 58501F 10 8 SCHEDULE 13G Page 5 of 9 Pages - -------------------------- ---------------------- Item 1(a). Name of Issuer: Medistem Laboratories, Inc. Item 1(b). Address of Issuer's Principal Executive Offices: 2027 E. Cedar St., Suite 102 Tempe, Arizona 85281 Item 2(a). Name of Person Filing. Vision Opportunity Master Fund, Ltd. Vision Capital Advisors, LLC Adam Benowitz Item 2(b). Address of Principal Business Office or, if None, Residence. Vision Opportunity Master Fund, Ltd.: c/o Citi Hedge Fund Services (Cayman) Limited P.O. Box 1748 Cayman Corporate Centre 27 Hospital Road, 5th Floor Grand Cayman KY1-1109 Cayman Islands Vision Capital Advisors, LLC Adam Benowitz: 20 W. 55th Street, 5th Floor New York, New York 10019 USA Item 2(c). Citizenship. Vision Opportunity Master Fund, Ltd. - Cayman Islands Vision Capital Advisors, LLC - Delaware Adam Benowitz - US Citizen Item 2(d). Title of Class of Securities: Common Stock, par value $0.0001 per share Item 2(e). CUSIP Number: 58501F 10 8 Item 3. If this statement is filed pursuant to ss.ss.240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: Not Applicable - -------------------------- ---------------------- CUSIP No. 58501F 10 8 SCHEDULE 13G Page 6 of 9 Pages - -------------------------- ---------------------- Item 4. Ownership. The following is information regarding the aggregate number and percentage of the class of securities of the Issuer identified in Item 1 as of September 12, 2007: (a) Vision Opportunity Master Fund, Ltd. - 14,236,466 Vision Capital Advisors, LLC - 14,236,466 Adam Benowitz - 14,236,466 (b) Percent of class: Vision Opportunity Master Fund, Ltd. - 9.99%* Vision Capital Advisors, LLC - 9.99%* Adam Benowitz - 9.99%* (c) Number of shares as to which the person has: Vision Opportunity Master Fund, Ltd. ------------------------------------ (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 14,236,466 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 14,236,466 Vision Capital Advisors, LLC ---------------------------- (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 14,236,466 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 14,236,466 Adam Benowitz ------------- (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 14,236,466 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 14,236,466 * Percent of class based on 132,955,693 shares of Common Stock outstanding as of July 30, 2007 as reported on the Issuer's quarterly report on Form 10-QSB filed on August 10, 2007. - -------------------------- ---------------------- CUSIP No. 58501F 10 8 SCHEDULE 13G Page 7 of 9 Pages - -------------------------- ---------------------- Item 5. Ownership of Five Percent or Less of a Class. Not Applicable Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not Applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8. Identification and Classification of Members of the Group. Not Applicable Item 9. Notice of Dissolution of Group. Not Applicable - -------------------------- ---------------------- CUSIP No. 58501F 10 8 SCHEDULE 13G Page 8 of 9 Pages - -------------------------- ---------------------- Item 10. Certification. Certification pursuant to ss.240.13d-1(c): By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. - -------------------------- ---------------------- CUSIP No. 58501F 10 8 SCHEDULE 13G Page 9 of 9 Pages - -------------------------- ---------------------- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: September 12, 2007 VISION OPPORTUNITY MASTER FUND, LTD.** By: /s/ ADAM BENOWITZ ------------------------------------- Name: Adam Benowitz Title: Portfolio Manager VISION CAPITAL ADVISORS, LLC** By: /s/ ADAM BENOWITZ ------------------------------------- Name: Adam Benowitz Title: Managing Member /s/ ADAM BENOWITZ ----------------------------------------- ADAM BENOWITZ** ** Vision Capital Advisors, LLC (the "Investment Manager") serves as investment manager to Vision Opportunity Master Fund, Ltd. (the "Master Fund"), the record owner of the subject securities. Adam Benowitz is the managing member of the Investment Manager and the Master Fund's portfolio manager. Each Reporting Person disclaims beneficial ownership of all securities other than those owned of record by such Reporting Person. EXHIBIT INDEX Exhibit No. Document - ----------- ----------------------------------------- 1 Joint Filing Agreement Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, par value $0.0001 per share, of Medistem Laboratories, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing. Dated: September 12, 2007 VISION OPPORTUNITY MASTER FUND, LTD. By: /s/ ADAM BENOWITZ ------------------------------------- Name: Adam Benowitz Title: Portfolio Manager VISION CAPITAL ADVISORS, LLC By: /s/ ADAM BENOWITZ ------------------------------------- Name: Adam Benowitz Title: Managing Member /s/ ADAM BENOWITZ ----------------------------------------- ADAM BENOWITZ -----END PRIVACY-ENHANCED MESSAGE-----